BOC Sciences - Products
London
BOC Sciences provides various research (bio)chemicals: inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities, metabolites, APIs, natural compounds, ADCs, and chiral compounds.
| Product | Description | |
|---|---|---|
| Levofloxacin Tetrafluoro Impurity 1 | An impurity of Levofloxacin, which is as efficacious as or more efficacious than that with ciprofloxacin in systemic as well as pyelonephritis infections in mice. Group: Pharmaceutical. CAS No. 110548-02-2. Pack Sizes: 2 mg. Product ID: B0185-473747. Molecular formula: Custom synthesis is available. Send your inquiries for more information. |  London |
| Levofloxacin USP Related Compound E | An impurity of Levofloxacin, which is as efficacious as or more efficacious than that with ciprofloxacin in systemic as well as pyelonephritis infections in mice. Group: Pharmaceutical. CAS No. 1346603-62-0. Pack Sizes: 25 mg. Product ID: B2694-338768. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Levomefolate | A natural, active form of folic acid used at the cellular level for DNA reproduction, the cysteine cycle and the regulation of homocysteine among other functions. It is a coenzymated form of folic acid and a more bioavailable alternative in dietary supplements. It has been proposed for treatment of cardiovascular disease. Group: Pharmaceutical. CAS No. 31690-09-2. Pack Sizes: 25 g. Product ID: B2693-090046. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Levomefolate Impurities | Levomefolate Impurities function as crucial benchmarks in pharmaceutical realms, underpinning the advancement and quality assurance of folate-centric medications. They are instrumental in validating the efficacy and safety profiles of therapies addressing major depressive disorder and cardiovascular conditions, offering profound insights into drug stability and bioavailability parameters. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Levomepromazine Impurities | Levomepromazine Impurities, essential to pharmaceutical scrutiny, underpin the assurance of purity and potency in levomepromazine, a cornerstone antipsychotic for managing schizophrenia, bipolar disorder, and acute pain. Their meticulous characterization fortifies safety and therapeutic efficacy, underscoring a pivotal role in pharmaceutical innovation and rigorous quality assurance. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Levomilnacipran Hydrochloride | Levomilnacipran (brand name Fetzima) is an antidepressant approved for the treatment of major depressive disorder in the United States. It was developed by Forest Laboratories and Pierre Fabre Group, and was approved by the Food and Drug Administration in July 2013. Levomilnacipran is the levo-enantiomer of milnacipran, and has similar effects and pharmacology, acting as a serotonin-norepinephrine reuptake inhibitor (SNRI). Uses: Antidepressive agents. Group: Pharmaceutical. CAS No. 175131-60-9. Pack Sizes: 200 mg. Product ID: B0084-263048. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Levonorgestrel butyrate | Levonorgestrel butyrate is a butyl prodrug of levonorgestrel, a widely-used steroidal progestin. Group: Pharmaceutical. CAS No. 86679-33-6. Pack Sizes: 1 g. Product ID: B1370-036551. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Levonorgestrel Impurities | Levonorgestrel Impurities, integral to biomedical exploration, underpin advancements in contraceptive drug development and quality control, particularly for levonorgestrel formulations. These impurities are crucial for guaranteeing drug purity and potency while aiding in the identification of adverse effects, essential for safe contraceptive practices and reproductive health oversight. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Levosimendan | Levosimendan is a calcium sensitizer acting through calcium-dependent binding to cardiac troponin C (cTnC). Uses: Vasodilator agents. Group: Pharmaceutical. CAS No. 141505-33-1. Pack Sizes: 1 g. Product ID: B2693-058487. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Levosimendan Impurities | Levosimendan Impurities are integral entities within the biomedical paradigm, pivotal for meticulous purity analysis of Levosimendan, a cornerstone heart failure therapeutic. Grasping these impurities underpins the enhancement of drug safety and efficacy, thus catalyzing advancements in cardiovascular treatment research and stimulating progressive pharmaceutical innovations. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Levosulpiride Impurities | Levosulpiride Impurities serve as fundamental constituents within the pharmaceutical realm, crucial for the stringent quality control and validation processes of Levosulpiride. Predominantly applied in addressing schizophrenia and dysthymia, these impurities are integral to safeguarding drug safety, efficacy, and aligning with stringent regulatory standards. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Levothyroxine EP Impurity F | An impurity of Thyroxine which is one of the two major hormones secreted by the thyroid gland and used to stimulate the consumption of oxygen and thus the metabolism of all cells and tissues in the body. Group: Pharmaceutical. CAS No. 911661-90-0. Pack Sizes: 5 mg. Product ID: B2694-413570. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Levothyroxine EP Impurity H | An impurity of Levothyroxine. Levothyroxine is used to treat hypothyroidism. Group: Pharmaceutical. CAS No. 2055-97-2. Pack Sizes: 25 mg. Product ID: B0136-412177. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Levothyroxine EP Impurity J | An impurity of Levothyroxine. Levothyroxine is used to treat hypothyroidism. Group: Pharmaceutical. CAS No. 4604-41-5. Pack Sizes: 25 mg. Product ID: B2694-390353. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Levothyroxine Impurities | Levothyroxine Impurities are crucial reference standards in the biomedical field, particularly in the quality control and formulation development of levothyroxine sodium tablets. These impurities help ensure drug efficacy and safety, addressing thyroid disorders like hypothyroidism by maintaining proper synthesis and dosage precision during drug manufacturing processes. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Levothyroxine sodium | Levothyroxine sodium is the hormone derived from thyroid gland. Group: Pharmaceutical. CAS No. 50809-32-0. Pack Sizes: 1 g. Product ID: B0084-069975. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Levothyroxine sodium hydrate | 3,3',5,5'-Tetraiodo-L-thyronine sodium saltm is the sodium salt of levothyroxine, a synthetic levoisomer of thyroxine (T4) that is similar to the endogenous hormone produced by the thyroid gland. In peripheral tissues, levothyroxine is deiodinated by 5'-deiodinase to form triiodothyronine (T3). T3 enters the cell and binds to nuclear thyroid hormone receptors, the activated hormone-receptor complex in turn triggers gene expression and produces proteins required in the regulation of cellular respiration, thermogenesis, cellular growth and differentiation, and the metabolism of proteins, carbohydrates and lipids. T3 also exhibits cardiostimulatory effects. Group: Pharmaceutical. CAS No. 25416-65-3. Pack Sizes: 100 g. Product ID: BAT-007813. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| LG 100268 | LG 100268 is a retinoid X receptor agonist with EC50 value of 4 nM. It can inhibit vinyl carbamate-induced lung tumor growth in mice in vivo. Group: Pharmaceutical. CAS No. 153559-76-3. Pack Sizes: 100 mg. Product ID: B1370-220651. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| L-Glutamic acid α-tert-butyl ester | L-Glutamic acid α-tert-butyl ester is an ester of L-Glutamic acid used in the synthesis of enantiopure isotopomers of amino acids. Group: Pharmaceutical. CAS No. 45120-30-7. Pack Sizes: 5 g. Product ID: BAT-004249. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| L-Glutamine Diethylamide Hydrochloride | L-Glutamine Diethylamide Hydrochloride. Group: Pharmaceutical. CAS No. 77529-90-9. Pack Sizes: 100 mg. Product ID: BAT-014380. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| L-Guanosine | L-Guanosine is a remarkable nucleoside widely utilized in exploring intricate neurological disorders, including Alzheimer's disease and dementia. Furthermore, L-Guanosine's pivotal role in RNA synthesis has propelled its prominence in the realm of antiviral drug development, specifically in the context of studying pernicious RNA viruses, such as hepatitis C. Group: Pharmaceutical. CAS No. 26578-09-6. Pack Sizes: 10 mg. Product ID: B2706-014745. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| L-Guluronic acid sodium salt | L-Guluronic acid sodium salt is a biomedical compound finding extensive applications in pharmaceutical drug development. Group: Pharmaceutical. CAS No. 32510-76-2. Pack Sizes: 25 mg. Product ID: B2705-001630. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| LH846 | LH846 is a selective inhibitor of CK1δ, which displays no inhibitory activity at CK2. It inhibits CK1δ-dependent phosphorylation and degradation of PER1 protein, showing to lengthen the circadian period in U2OS cells, with minimal effect on amplitude. Group: Pharmaceutical. CAS No. 639052-78-1. Pack Sizes: 50 mg. Product ID: B0084-463302. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Liangshanin A | Liangshanin A is a natural diterpenoid found in the herbs of Rabdosia bulleyana. Group: Pharmaceutical. CAS No. 122717-54-8. Pack Sizes: 1 mg. Product ID: NP1336. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| (-)-Licarin A | (-)-Licarin A is a natural product found in Magnolia dodecapetala and Magnolia kachirachirai. Group: Pharmaceutical. CAS No. 51020-86-1. Pack Sizes: 5 mg. Product ID: NP3944. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Licochalcone A | Licochalcone A is a chalconoid, a type of natural phenols. It can be isolated from root of Glycyrrhiza glabra (liquorice) or Glycyrrhiza inflata. It is a potent membrane-active agent that transforms normal erythrocytes into echinocytes. It exhibits potent antimalarial activity and might be developed into a new antimalarial drug. It had anti-tumor activity in all cell lines tested and enhanced the effect of paclitaxel and vinblastine chemotherapy. Group: Pharmaceutical. CAS No. 58749-22-7. Pack Sizes: 100 mg. Product ID: NP0988. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Licochalcone B | Licochalcone B is extracted from the roots of Glycyrrhiza glabra L. It inhibits the adhesion,invasion and metastasis of human malignant bladder cancer T24 cells. It could significantly reduce the LPS-induced production of NO, TNFalpha and MCP-1. Group: Pharmaceutical. CAS No. 58749-23-8. Pack Sizes: 10 mg. Product ID: NP0992. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Licoisoflavone A | Licoisoflavone A, a potential MRP inhibitor, is a natural flavonoid derived from the roots of Glycyrrhiza uralensis Fisch. It inhibits lipid peroxidation with an IC50 of 7.2 μM. Licoisoflavone A and Licoisoflavone B inhibit copper-induced protein oxidative modification of mice brain homogenate in vitro. Group: Pharmaceutical. CAS No. 66056-19-7. Pack Sizes: 5 mg. Product ID: BBF-05885. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Liensinine | Liensinine is extracted from the plantule of Nelumbo nucifera Gaertn. It is a kind of isoquinoline alkaloid, and it can antagonize the ventricular arrhythmias. Group: Pharmaceutical. CAS No. 2586-96-1. Pack Sizes: 50 mg. Product ID: B0005-464369. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Liensinine diperchlorate | Liensinine diperchlorate can be extracted from the plantule of Nelumbo nucifera Gaertn. Group: Pharmaceutical. CAS No. 5088-90-4. Pack Sizes: 10 mg. Product ID: B2703-464366. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Liensinine perchlorate | Liensinine Perchlorate is extracted from the plantule of Nelumbo nucifera Gaertn. Group: Pharmaceutical. CAS No. 2385-63-9. Pack Sizes: 50 mg. Product ID: B2703-302227. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Lifitegrast | Lifitegrast is a Lymphocyte Function-Associated Antigen-1 (LFA-1) antagonist. It is used for the treatment of keratoconjunctivitis sicca (dry eye syndrome). It inhibits T cell-mediated inflammation by blocking the binding of two important cell surface proteins, thus lessening overall inflammatory responses. It was initially developed by SARcode Bioscience, which was acquired by Shire in 2013. Group: Pharmaceutical. CAS No. 1025967-78-5. Pack Sizes: 500 mg. Product ID: B0084-474974. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| lignin | Lignin, alkali can be used as a surface treatment agent for composites of natural fibers with petroleum based resins. It can be used as a biosorbent for potential applications in removing toxic metal ions from wastewater. Group: Pharmaceutical. CAS No. 8068-5-1. Pack Sizes: 250 g. Product ID: B1370-009688. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Lignin, organosolv | It is obtained from the delignification of lignocellulosic substances (wood, spent liquor, or other agricultural fiber source) by using an organic solvent. Group: Pharmaceutical. CAS No. 8068-3-9. Pack Sizes: 500 g. Product ID: B1370-005567. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Ligustrazine Hydrochloride | Ligustrazine Hydrochloride has certain protection effect on the vascular endothelium undergoing CPB, and lower excessive activation of coagulation reaction and inflammation reaction in patients undergoing CPB. Uses: Increased coronary flow. Group: Pharmaceutical. CAS No. 76494-51-4. Pack Sizes: 100 mg. Product ID: B0005-465019. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Ligustroflavone | Ligustroflavone is isolated from Ligustrum vulgare, which shows anti-inflammatory and antioxidant activity. It has the potential as a calcium-sensing receptor (CaSR) antagonist. Uses: Anti-inflammatory. Group: Pharmaceutical. CAS No. 260413-62-5. Pack Sizes: 25 mg. Product ID: NP1978. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Ligustroside | Ligustroside is isolated from the seeds of Ligustrum lucidum. Uses: Anti-inflammatory. Group: Pharmaceutical. CAS No. 35897-92-8. Pack Sizes: 1 mg. Product ID: NP3839. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| LIK066 | LIK066 is a potent sodium-glucose transporter 1 and sodium-glucose transporter 2 inhibitor originated by Novartis Pharmaceuticals Corporation IC50 with value of 22.0 nM against human SGLT1 and 0.5 nM against human SGLT2. In Apr 2016, Novartis completed a phase II trial for Type 2 diabetes mellitus in USA. Uses: Type 2 diabetes mellitus. Group: Pharmaceutical. CAS No. 1291094-73-9. Pack Sizes: 10 mg. Product ID: B2693-475275. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Limaprost Impurities | Limaprost Impurities are pivotal in the biomedical domain for evaluating and improving the purity of Limaprost, a vasodilator used in treating conditions like Buerger's disease and lower limb ischemia. Studying these impurities aids drug development by ensuring the safety and efficacy of Limaprost formulations. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Limonin | Limonin is a triterpenoid enriched in citrus fruits, which has antivirus and antitumor ability. Uses: Anticancer; antioxidant; anti-inflammatory. Group: Pharmaceutical. CAS No. 1180-71-8. Pack Sizes: 5 g. Product ID: NP6981. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Linaclotide | Linaclotide is a peptide agonist of guanylate cyclase 2C that is undergoing clinical trials for use in treating abdominal pain in patients with irritable bowel syndrome (IBS) accompanied by constipation. The drug also has promising outlooks for the treatment of gastroparesis, ulcerative colitis, chronic intestinal pseudo-obstruction (CIPO), and inertia coli as well. Group: Pharmaceutical. CAS No. 851199-59-2. Pack Sizes: 50 mg. Product ID: BAT-010098. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Linaclotide Impurities | Linaclotide Impurities, often utilized in drug development and quality control processes, play a critical role in the synthesis and validation of linaclotide, an approved medication for irritable bowel syndrome with constipation (IBS-C). These impurities help ensure the drug's efficacy, safety, and consistency in treating gastrointestinal disorders. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Linagliptin | Linagliptin is a novel potent and selective dipeptidyl peptidase-4 (DPP-4) inhibitor with potential use in the treatment of type 2 diabetes. Uses: The treatment of type 2 diabetes. Group: Pharmaceutical. CAS No. 668270-12-0. Pack Sizes: 2.5 g. Product ID: NP2669. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Linagliptin-[d4] | Linagliptin-[d4] is a labelled form of Linagliptin, a medication used to treat diabetes mellitus type 2. Group: Pharmaceutical. CAS No. 2140263-92-7. Pack Sizes: 10 mg. Product ID: BLP-013101. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Linagliptin Impurities | Linagliptin Impurities hold a paramount position in the biomedical sector, instrumental for pharmaceutical research and quality control paradigms. These impurities facilitate the synthesis and evaluation of linagliptin, a pivotal type 2 diabetes treatment via dipeptidyl peptidase-4 enzyme inhibition, thereby assuring the drug's purity and therapeutic effectiveness. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Linagliptin Impurity 10 (S-Isomer) | a novel potent and selective dipeptidyl peptidase-4 (DPP-4) inhibitor with potential use in the treatment of type 2 diabetes. Group: Pharmaceutical. CAS No. 668270-11-9. Pack Sizes: 50 mg. Product ID: B0012-473823. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Linagliptin Impurity 7 Hydrochloride | An impurity of Linagliptin, a novel potent and selective dipeptidyl peptidase-4 (DPP-4) inhibitor with potential use in the treatment of type 2 diabetes. Group: Pharmaceutical. Pack Sizes: 50 mg. Product ID: B1370-449757. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Linagliptin Impurity B | An impurity of Linagliptin, a novel potent and selective dipeptidyl peptidase-4 (DPP-4) inhibitor with potential use in the treatment of type 2 diabetes. Group: Pharmaceutical. CAS No. 2138392-83-1. Pack Sizes: 10 mg. Product ID: B2694-473825. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Linagliptin Impurity E | An impurity of Linagliptin, a novel potent and selective dipeptidyl peptidase-4 (DPP-4) inhibitor with potential use in the treatment of type 2 diabetes. Group: Pharmaceutical. CAS No. 1446263-38-2. Pack Sizes: 10 mg. Product ID: B2694-242668. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Linagliptin Methyldimer | An impurity of Linagliptin, a novel potent and selective dipeptidyl peptidase-4 (DPP-4) inhibitor with potential use in the treatment of type 2 diabetes. Group: Pharmaceutical. CAS No. 1418133-47-7. Pack Sizes: 10 mg. Product ID: B2694-473827. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Linagliptin N-Acetyl Impurity | An impurity of Linagliptin. Linagliptin is a dipeptidyl peptidase-4 inhibitor with a hpyerglycemic activity. It was approved for the treatment of diabetes mellitus type 2. Group: Pharmaceutical. CAS No. 1803079-49-3. Pack Sizes: 50 mg. Product ID: B0012-007233. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Linagliptin N-Boc Impurity | An impurity of Linagliptin. Linagliptin is a dipeptidyl peptidase-4 inhibitor with a hpyerglycemic activity. It was approved for the treatment of diabetes mellitus type 2. Group: Pharmaceutical. CAS No. 668273-75-4. Pack Sizes: 50 mg. Product ID: B0012-007234. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Linarin | Linarin is a flavone glycoside isolated from the herb of Uncaria sinensis (Oliv.) Havil. It is also an impurity of Diosmin, a medication used for the treatment of various disorders of blood vessels. Group: Pharmaceutical. CAS No. 480-36-4. Pack Sizes: 100 mg. Product ID: NP1809. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Linaroside | Linaroside is a flavonoid glycoside isolated from some species of Linaria. Group: Pharmaceutical. CAS No. 53452-12-3. Pack Sizes: 1 mg. Product ID: NP2433. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Lincomycin 2-Phosphate | Lincomycin 2-Phosphate (Clindamycin Phosphate EP Impurity F) is an impurity of Clindamycin, which is a semi-synthetic antibiotic prepared from Lincomycin. Group: Pharmaceutical. CAS No. 27480-30-4. Pack Sizes: 5 mg. Product ID: B2694-337341. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Lincomycin Impurities | Lincomycin Impurities are key reference standards in the biomedical industry, utilized for ensuring quality control and purity of lincomycin drug formulations. These impurities facilitate the accurate assessment and validation of analytical methods crucial for treating bacterial infections, particularly those caused by Gram-positive bacteria. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Linderaspirone A | Linderaspirone A, that is extracted from the roots of Lindera aggregata( Sims) Kosterm, showed significant activity against glucosamine-induced insulin resistance. Group: Pharmaceutical. CAS No. 1235126-46-1. Pack Sizes: 1 mg. Product ID: NP4320. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Linezolid | Linezolid inhibits initiation complex formation with either the 30S or the 70S ribosomal subunits from Escherichia coli. Linezolid is a synthetic oxazolidinone antibiotic active against a wide range of Gram-positive bacteria, including resistant strains of several species, such as MRSA and penicillin-resistant pneumococci. Group: Pharmaceutical. CAS No. 165800-03-3. Pack Sizes: 50 mg. Product ID: BBF-04161. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Linezolid-[d3] | Linezolid-[d3] is the labelled analogue of Linezolid, which is an antibiotic used to treat infections caused by Gram-positive bacteria. Group: Pharmaceutical. CAS No. 1127120-38-0. Pack Sizes: 5 mg. Product ID: BLP-011205. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Linezolid Impurities | Linezolid Impurities play a critical role in the pharmaceutical industry, particularly in ensuring the quality and efficacy of the antibacterial agent Linezolid. These impurities need to be identified and quantified, as they can impact drug safety and therapeutic effectiveness, thus aiding in the rigorous assessment of drug formulations used to treat bacterial infections. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Linezolid Impurity 42 | An impurity of Linezolid. Linezolid inhibits initiation complex formation with either the 30S or the 70S ribosomal subunits from Escherichia coli. Group: Pharmaceutical. CAS No. 725676-93-7. Pack Sizes: 10 mg. Product ID: B2694-338786. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Linezolid Impurity 44 | An impurity of Linezolid. Linezolid inhibits initiation complex formation with either the 30S or the 70S ribosomal subunits from Escherichia coli. Group: Pharmaceutical. CAS No. 183805-10-9. Pack Sizes: 2 mg. Product ID: B2694-338787. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Linezolid Impurity PNU140155 | N-[(2R)-3-[[3-Fluoro-4-(4-morpholinyl)phenyl]amino]-2-hydroxypropyl]acetamide is an impurity of Linezolid. Group: Pharmaceutical. CAS No. 333753-67-6. Pack Sizes: 100 mg. Product ID: B0073-472426. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Linezolid N-Oxide | Linezolid N-oxide is a derivative of Linezolid, an oxazolidinone antimicrobial that is used to treat infections against gram-positive bacteria, especially those that are drug-resistant. Linezolid works by inhibiting bacterial protein synthesis. Group: Pharmaceutical. CAS No. 189038-36-6. Pack Sizes: 100 mg. Product ID: B0073-472424. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Linifanib | Description of Linifanib: Linifanib is an orally bioavailable, small-molecule receptor tyrosine kinase (RTK) inhibitor with potential antineoplastic activity. Linifanib inhibits members of the vascular endothelial growth factor (VEGF) and platelet-derived growth factor (PDGF) receptor families; it exhibits much less activity against unrelated RTKs, soluble tyrosine kinases, or serine/threonine kinases. This agent does not have a general antiproliferative effect due to its high dose requirement. However, linifanib may exhibit potent antiproliferative and apoptotic effects on tumor cells whose proliferation is dependent on mutant kinases, such as fms-related tyrosine kinase receptor-3 (FLT3). Group: Pharmaceutical. CAS No. 796967-16-3. Pack Sizes: 200 mg. Product ID: B0084-151820. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Linolenyl alcohol | Linolenyl alcohol. Group: Pharmaceutical. CAS No. 506-44-5. Pack Sizes: 1 g. Product ID: B1370-302242. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Liothyronine Sodium | Liothyronine Sodium is the most potent form of thyroid hormone acting on the body to increase the basal metabolic rate, affect protein synthesis. Group: Pharmaceutical. CAS No. 55-06-1. Pack Sizes: 1 g. Product ID: BAT-008129. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Lipid 5 | Lipid 5 is a cationic amino lipid. LNPs incorporating Lipid 5 (from Sabnis et al.) demonstrated potent delivery of mRNA in primates but also were rapidly cleared from the body resulting in low toxicity. Group: Pharmaceutical. CAS No. 2089251-33-0. Pack Sizes: 100 mg. Product ID: B1370-376226. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Lipid ALC-0159 | ALC-0159 is a PEG/lipid conjugate (i.e. PEGylated lipid), specifically, it is the N,N-dimyristylamide of 2-hydroxyacetic acid, O-pegylated to a PEG chain mass of about 2 kilodaltons (corresponding to about 45-46 ethylene oxide units per molecule of N,N-dimyristyl hydroxyacetamide). Group: Pharmaceutical. CAS No. 1849616-42-7. Pack Sizes: 500 mg. Product ID: B2699-051402. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Lipid ALC-0315 | ALC-0315 can be used to form lipid nanoparticle (LNP, non-viral gene delivery system). Group: Pharmaceutical. CAS No. 2036272-55-4. Pack Sizes: 250 mg. Product ID: B2699-358155. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
Would you like to list your products on UK Chemical Suppliers?
Our database is helping our users find suppliers everyday.